Legal & General Group Plc increased its position in Teleflex Incorporated (NYSE:TFX) by 42.0% during the first quarter, Holdings Channel reports. The fund owned 68,000 shares of the medical technology company’s stock after buying an additional 20,097 shares during the period. Legal & General Group Plc’s holdings in Teleflex were worth $13,175,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in TFX. Norges Bank bought a new stake in Teleflex during the fourth quarter worth about $62,676,000. FMR LLC increased its stake in Teleflex by 46.5% in the first quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock worth $157,263,000 after buying an additional 257,649 shares during the last quarter. State Street Corp increased its stake in Teleflex by 14.9% in the fourth quarter. State Street Corp now owns 1,332,507 shares of the medical technology company’s stock worth $214,718,000 after buying an additional 172,780 shares during the last quarter. Smith Asset Management Group LP bought a new stake in Teleflex during the first quarter worth about $17,484,000. Finally, Assenagon Asset Management S.A. bought a new stake in Teleflex during the fourth quarter worth about $11,239,000. Institutional investors own 93.33% of the company’s stock.
Teleflex Incorporated (NYSE TFX) traded down 0.061% on Wednesday, hitting $203.395. 10,799 shares of the stock were exchanged. Teleflex Incorporated has a one year low of $136.53 and a one year high of $211.22. The company has a 50 day moving average of $200.28 and a 200 day moving average of $184.94. The stock has a market capitalization of $9.15 billion, a P/E ratio of 42.216 and a beta of 1.05.
Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 4th. The medical technology company reported $1.80 EPS for the quarter, topping the Zacks’ consensus estimate of $1.69 by $0.11. The business had revenue of $487.90 million for the quarter, compared to analyst estimates of $472.81 million. Teleflex had a net margin of 11.75% and a return on equity of 16.17%. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.52 earnings per share. On average, equities research analysts forecast that Teleflex Incorporated will post $8.16 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 15th. Stockholders of record on Monday, May 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date was Thursday, May 11th. Teleflex’s dividend payout ratio is presently 28.22%.
A number of research analysts have recently weighed in on TFX shares. Deutsche Bank AG raised their price target on shares of Teleflex from $192.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, March 15th. Needham & Company LLC started coverage on shares of Teleflex in a report on Monday, March 6th. They set a “buy” rating and a $221.00 price target on the stock. Zacks Investment Research downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, May 20th. Stephens upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating in a report on Friday, February 24th. Finally, Jefferies Group LLC restated a “hold” rating on shares of Teleflex in a report on Monday, March 27th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $216.17.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $199.93, for a total value of $39,986.00. Following the sale, the director now owns 8,080 shares of the company’s stock, valued at $1,615,434.40. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Stuart A. Randle sold 2,500 shares of the business’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total transaction of $514,175.00. Following the completion of the sale, the director now directly owns 7,532 shares in the company, valued at approximately $1,549,106.44. The disclosure for this sale can be found here. In the last three months, insiders sold 10,146 shares of company stock worth $1,996,554. 2.39% of the stock is currently owned by insiders.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.